Biological E Corbevax safe, offers high antibody levels: NTAGI Chairman Ruchika Sharma16 Feb 2022 12:39 PM ISTNew Delhi: India's third homegrown Covid-19 vaccine Corbevax is safe and offers good immunogenicity and higher antibody levels than some other vector...
CDSCO panel recommends Biological E Corbevax for emergency use among 12 to 18 year olds Ruchika Sharma15 Feb 2022 11:52 AM ISTThe recommendation has been sent to the DCGI for final approval.
COVID-19: Biological E seeks DCGI emergency use nod for Corbevax for 12-18 years old Ruchika Sharma14 Feb 2022 11:39 AM ISTThe Corbevax vaccine is administered through intramuscular route with two doses scheduled 28 days apart.
Biological E receives Govt purchase order for 5 crore Corbevax doses Ruchika Sharma7 Feb 2022 11:00 AM ISTThe cost implication of five crore dosed of Corbevax at the rate of Rs 145 per dose plus GST as applicable come to Rs 725 plus GST as applicable.
Biological E in talks with WHO over Corbevax approval, says Developer Ruchika Sharma31 Dec 2021 12:00 PM ISTHouston: Corbevax, a 'recombinant protein sub-unit' vaccine developed by Texas-based vaccine developers, was recently granted emergency approval by...
Biological E bags DCGI nod for Corbevax trials as booster dose Ruchika Sharma30 Dec 2021 12:39 PM ISTNew Delhi: The Drug Controller General of India (DCGI) has given approval to the Hyderbad-based pharmaceutical company Biological E to conduct phase 3...
Biological E plans to make 100 million Corbevax doses per month from February Ruchika Sharma29 Dec 2021 1:15 PM ISTNew Delhi: Biological E. Limited plans to complete production at a rate of 75 million doses of its COVID-19 vaccine Corbevax per month, anticipating...
Anti-COVID pill Molnupiravir, Covovax, Corbevax get CDSCO panel emergency use nod Ruchika Sharma28 Dec 2021 11:19 AM ISTAll the recommendations have been sent to the Drug Controller General of India (DCGI) for final approval.
Biological E seeks DCGI nod for phase-3 trial of Corbevax as booster dose Ruchika Sharma13 Oct 2021 11:41 AM ISTNew Delhi: Hyderabad-based pharmaceutical company Biological E has sought permission from India's drug regulator to conduct the phase-3 clinical trial...
DCGI nod to phase 2, 3 trials of Biological E Corbevax in children Medical Dialogues Team2 Sept 2021 12:31 PM ISTNew Delhi: The Drugs Controller General of India (DCGI) on Wednesday granted permission to Hyderabad-based Biological E Limited to conduct phase 2/3...
Provide more safety, immunogenicity data: CDSCO panel tells Biological E on trial of COVID vaccine Medical Dialogues Team3 Aug 2021 3:50 PM ISTNew Delhi: Following the proposal presented by Biological E to conduct a Phase II/III clinical trial of its Covid-19 vaccine containing the SARSCoV-2...
Biological E expects to launch COVID vaccine Corbevax by September end: Sources Ruchika Sharma27 July 2021 2:27 PM ISTNew Delhi: The Hyderabad-based pharmaceutical company Biological E is expected to launch its COVID-19 vaccine Corbevax by September end in India, said...
